481 related articles for article (PubMed ID: 33006723)
1. HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome.
Gigli GL; Vogrig A; Nilo A; Fabris M; Biasotto A; Curcio F; Miotti V; Tascini C; Valente M
Neurol Sci; 2020 Dec; 41(12):3391-3394. PubMed ID: 33006723
[TBL] [Abstract][Full Text] [Related]
2. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic.
Uncini A; Vallat JM; Jacobs BC
J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1105-1110. PubMed ID: 32855289
[TBL] [Abstract][Full Text] [Related]
3. Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2.
Juliao Caamaño DS; Alonso Beato R
J Clin Neurosci; 2020 Jul; 77():230-232. PubMed ID: 32410788
[TBL] [Abstract][Full Text] [Related]
4. Guillain-Barré Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Detection and Coronavirus Disease 2019 in a Child.
Khalifa M; Zakaria F; Ragab Y; Saad A; Bamaga A; Emad Y; Rasker JJ
J Pediatric Infect Dis Soc; 2020 Sep; 9(4):510-513. PubMed ID: 32652520
[TBL] [Abstract][Full Text] [Related]
5. A Rare Axonal Variant of Guillain-Barré Syndrome as a Neurological Complication of COVID-19 Infection.
Agha Abbaslou M; Karbasi M; Mozhdehipanah H
Arch Iran Med; 2020 Oct; 23(10):718-721. PubMed ID: 33107316
[TBL] [Abstract][Full Text] [Related]
6. Guillain Barre syndrome associated with COVID-19 infection: A case report.
Sedaghat Z; Karimi N
J Clin Neurosci; 2020 Jun; 76():233-235. PubMed ID: 32312628
[TBL] [Abstract][Full Text] [Related]
7. Acute Motor Axonal Neuropathy Related to COVID-19 Infection: A New Diagnostic Overview.
Petrelli C; Scendoni R; Paglioriti M; Logullo FO
J Clin Neuromuscul Dis; 2020 Dec; 22(2):120-121. PubMed ID: 33214404
[No Abstract] [Full Text] [Related]
8. COVID-19-associated Guillain-Barré syndrome: The early pandemic experience.
Caress JB; Castoro RJ; Simmons Z; Scelsa SN; Lewis RA; Ahlawat A; Narayanaswami P
Muscle Nerve; 2020 Oct; 62(4):485-491. PubMed ID: 32678460
[TBL] [Abstract][Full Text] [Related]
9. Guillain-Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection.
Sancho-Saldaña A; Lambea-Gil Á; Liesa JLC; Caballo MRB; Garay MH; Celada DR; Serrano-Ponz M
Clin Med (Lond); 2020 Jul; 20(4):e93-e94. PubMed ID: 32518103
[TBL] [Abstract][Full Text] [Related]
10. Facing acute neuromuscular diseases during COVID-19 pandemic: focus on Guillain-Barré syndrome.
Galassi G; Marchioni A
Acta Neurol Belg; 2020 Oct; 120(5):1067-1075. PubMed ID: 32696312
[TBL] [Abstract][Full Text] [Related]
11. Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease.
Abrams RMC; Kim BD; Markantone DM; Reilly K; Paniz-Mondolfi AE; Gitman MR; Choo SY; Tse W; Robinson-Papp J
J Neurovirol; 2020 Oct; 26(5):797-799. PubMed ID: 32720233
[TBL] [Abstract][Full Text] [Related]
12. Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports.
Rahimi K
Neurol Sci; 2020 Nov; 41(11):3149-3156. PubMed ID: 32876777
[TBL] [Abstract][Full Text] [Related]
13. A Case of Guillain-Barré Syndrome Associated With COVID-19.
Rajdev K; Victor N; Buckholtz ES; Hariharan P; Saeed MA; Hershberger DM; Bista S
J Investig Med High Impact Case Rep; 2020; 8():2324709620961198. PubMed ID: 32981333
[TBL] [Abstract][Full Text] [Related]
14. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
Scheidl E; Canseco DD; Hadji-Naumov A; Bereznai B
J Peripher Nerv Syst; 2020 Jun; 25(2):204-207. PubMed ID: 32388880
[TBL] [Abstract][Full Text] [Related]
15. COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain-Barré syndrome.
Massa F; Vigo T; Bellucci M; Giunti D; Emanuela MM; Visigalli D; Capodivento G; Cerne D; Assini A; Boni S; Rizzi D; Narciso E; Grisanti GS; Coco E; Uccelli A; Schenone A; Franciotta D; Benedetti L
Neurol Sci; 2024 Mar; 45(3):849-859. PubMed ID: 38169013
[TBL] [Abstract][Full Text] [Related]
16. Guillain-Barré syndrome after covid-19 infection.
García-Manzanedo S; López de la Oliva Calvo L; Ruiz Álvarez L
Med Clin (Barc); 2020 Oct; 155(8):366. PubMed ID: 32718718
[No Abstract] [Full Text] [Related]
17. SARS-CoV-2-Associated Guillain-Barre Syndrome With Good Response to Plasmapheresis.
Granger A; Omari M; Jakubowska-Sadowska K; Boffa M; Zakin E
J Clin Neuromuscul Dis; 2020 Sep; 22(1):58-59. PubMed ID: 32833726
[No Abstract] [Full Text] [Related]
18. Guillain-Barré syndrome related to COVID-19 infection.
Alberti P; Beretta S; Piatti M; Karantzoulis A; Piatti ML; Santoro P; Viganò M; Giovannelli G; Pirro F; Montisano DA; Appollonio I; Ferrarese C
Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32350026
[No Abstract] [Full Text] [Related]
19. Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital.
Ottaviani D; Boso F; Tranquillini E; Gapeni I; Pedrotti G; Cozzio S; Guarrera GM; Giometto B
Neurol Sci; 2020 Jun; 41(6):1351-1354. PubMed ID: 32399950
[TBL] [Abstract][Full Text] [Related]
20. Guillain-Barré syndrome: The first documented COVID-19-triggered autoimmune neurologic disease: More to come with myositis in the offing.
Dalakas MC
Neurol Neuroimmunol Neuroinflamm; 2020 Sep; 7(5):. PubMed ID: 32518172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
